BINDING OF ALA-SUBSTITUTED ANALOGS OF HA306-320 TO DR1101, DR1301, AND DR0402 MOLECULES - CORRELATION OF DR-PEPTIDE INTERACTIONS WITH RECOGNITION BY A SINGLE TCR
D. Zeliszewski et al., BINDING OF ALA-SUBSTITUTED ANALOGS OF HA306-320 TO DR1101, DR1301, AND DR0402 MOLECULES - CORRELATION OF DR-PEPTIDE INTERACTIONS WITH RECOGNITION BY A SINGLE TCR, Human immunology, 50(1), 1996, pp. 61-69
We tested the hypothesis that a cross-reactive T-cell clone could reco
gnize HA306-320 peptide complexed to autologous HLA-DR1101, and also t
o allogenic HLA-DR0402 and HLA-DR1301 molecules, because of similar or
ientations of HA306-320 side chains in the groove of the three DR mole
cules. To approach peptide orientations in each HLA groove we compared
the capacity of Ala-monosubstituted analogs to bind and be presented
by DR1101, DR0402, and DR1301. Results indicated that the orientation
of HA306-320 in DR1101 was grossly similar to the known orientation of
HA307-319 in DR0101. Data suggested many similarities in peptide orie
ntations in DR0402 and DR1301 as well. However, differences in binding
were also observed. Ala substitution of Y309 had much less effect on
peptide binding ro DR1301 and DR0402 than to DR1101 and Ala-substituti
on of T314 increased affinity for DR1301 but not for DR1101 and DR0402
. These alterations of peptide-DR interactions were probably communica
ted to the upper peptide surface. Indeed, the levels of T-cell clone r
eactivities against analogs mutated at positions predicted to face the
TCR were lower when complexed to allogeneic DR molecules than when co
mplexed to DR1101. Yet these epitopic alterations are likely subtle, s
ince the decreased reactivity of the clone to allogeneic molecules cou
ld be compensated by peptide substitution at Y309, predicted to face t
he MHC.